Sign up for our e-newsletter to get headline health news and advanced information on new courses and conferences. |
|
Go Back
|
Title |
: |
Conversations in Primary Care: March 10, 2018 |
|
: |
03.10.18CPC |
|
: |
Free |
| : |
Mar 10 2018 |
| : |
Mar 10 2018 |
| : |
Primary Care Medicine |
| : |
Primary Care Providers |
| : |
Live Virtual Conferences |
| : |
4 hours |
| : |
4.0 AMA PRA Category I Credit(s) ™
4.0 AANP Contact hour(s) which includes 1.0 pharmacology hour(s) |
 |
|
There is no registration fee for this CME live virtual conference!
March 10, 2018
Broadcast Live from Ft. Lauderdale, FL
Start Time: 10:00 am EST
Program Summary:
Join Dr. Gregg Sherman and Dr. Matt Rosenberg and stay on track to fulfill your CME requirements from the comfort of your home. Utilizing an interactive, moderator led format, this program will present discussions with national thought leaders to help you hone your skills in the diagnosis and management of patients you are likely encountering in your practice. You will be able to interact with the faculty real-time to get your questions answered. Learning Objectives:
At the conclusion of this program, participants should be able to: Identify and describe the clinical features of psoriatic skin and joint disease; Review and discuss associated comorbidities and emerging bio factors and their significance in the management of psoriatic disease; Discuss the expanding and dynamically changing treatment paradigm for psoriasis and its related disorders; Review and interpret up to date evidence-based clinical trial data and the latest treatments available for the management of psoriatic disease Recognize actinic skin damage and appropriate treatment options; Identify clinical features of basal cell carcinoma and management strategies; Recognize when to suspect squamous cell carcinoma and how to manage in practice; Identify various forms of melanoma and current treatment options
Recognize patient populations at risk for testosterone deficiency; Discuss the relationship between testosterone deficiency, metabolic syndrome and vascular disease; Understand the controversy surrounding testosterone replacement and risk for cardiovascular disease Utilize evidence-based strategies to diagnose patients presenting with headache; Identify associated conditions (e.g. depression), and red flags for potentially life-threatening causes of headache; Use evidence-based recommendations to prescribe treatment for patients presenting with acute or emergent headache pain; Develop collaborative management plans, emphasizing patient education on avoiding triggers that cause headache, and adherence to prescribed treatment strategies
Agenda*
10:00-10:10 AM
| | Welcome Remarks
Gregg Sherman, MD
|
10:10-11:10 | | Confronting Psoriatic Disease: Putting New Tools to Work
Paul Yamauchi, MD, FAAD and Matt T. Rosenberg, MD | | 11:10-12:10 PM | | Detection of Skin Cancers
Paul Yamauchi, MD, FAAD and Gregg Sherman, MD
| 12:10-12:40
|
| Break
| 12:40-1:40
| | Testosterone, the FDA, and CVD Risk Controversies
Matt T. Rosenberg, MD and Jeffrey Unger, MD | | 1:40-2:40 | | Managing Migraine: Primary Care for Primary Headaches
Jeffrey Unger, MD and Gregg Sherman, MD | 2:40-2:45
|
| Closing Remarks
Gregg Sherman, MD | * Subject to Change Faculty
Matt T. Rosenberg, MD
Director, Mid-Michigan Health Centers
Jackson, MI Jeffrey Unger, MD
Director, Unger Primary Care Concierge Medical Group
Rancho Cucamonga, CA
Director of Metabolic Studies, Catalina Research Institute
Montclair, CA Paul Yamauchi, MD, FAAD
Clinical Assistant Professor of Dermatology
David Geffen School of Medicine
University of California,
Los Angeles, CA
Moderators
Matt T. Rosenberg, MD
Director, Mid-Michigan Health Centers
Jackson, MI Gregg Sherman, MD
Family Practice
Plantation, FL
Planning Committee
Michelle Frisch, MPH, CHCP
National Association for Continuing Education
Plantation, FL Daniela Hiedra, BA
Activity Director
National Association for Continuing Education
Plantation, FL Joshua F. Kilbridge
President and Creative Director
Kilbridge Associates
San Francisco, CA Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education
Plantation, FL Gregg Sherman, MD
Course Director
Chief Medical Officer
National Association for Continuing Education
Plantation, FL
|
National Association for Continuing Education
|
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The National Association for Continuing Education designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 4 contact hours of continuing education including 1.0 pharmacology hour. |
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials. |
This educational activity is supported by an educational grant from Novartis Pharmaceuticals Corporation. |
|
